---
title: Attrition in the First Three Therapy Lines in Patients with Advanced Breast
  Cancer in the German Real-World PRAEGNANT Registry
date: '2024-05-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38817595/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240601181254&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Background With more effective therapies for patients with advanced breast
  cancer (aBC), therapy sequences are becoming increasingly important. However, some
  patients might drop out of the treatment sequence due to deterioration of their
  life status. Since little is known about attrition in the real-world setting, this
  study assessed attrition in the first three therapy lines using a real-world registry.
  Methods Patients with information available on the first three therapy lines were
  ...
disable_comments: true
---
Background With more effective therapies for patients with advanced breast cancer (aBC), therapy sequences are becoming increasingly important. However, some patients might drop out of the treatment sequence due to deterioration of their life status. Since little is known about attrition in the real-world setting, this study assessed attrition in the first three therapy lines using a real-world registry. Methods Patients with information available on the first three therapy lines were ...